Multiple myeloma: Plasma cell contamination in leukaferesis collections is reduced by an effective in vivo purging with high dose sequential chemotherapy

被引:0
|
作者
Omede, P [1 ]
Palumbo, A [1 ]
Giaretta, F [1 ]
Ravaglia, R [1 ]
Dominietto, A [1 ]
Triolo, S [1 ]
Tarella, C [1 ]
Pileri, A [1 ]
Boccadoro, M [1 ]
机构
[1] UNIV EMATOL,AZIENDA OSPED S GIOVANNI,SPERIMENTALE DIV,DIPARTIMENTO MED & ONCOL,TURIN,ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1140 / 1140
页数:1
相关论文
共 50 条
  • [1] Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses
    Omede, P
    Tarella, C
    Palumbo, A
    Argentino, C
    Caracciolo, D
    Corradini, P
    Dominietto, A
    Giaretta, F
    Ravaglia, R
    Triolo, R
    Triolo, S
    Pileri, A
    Boccadoro, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) : 685 - 691
  • [2] High-dose sequential chemotherapy in the treatment of multiple myeloma.
    Canales, M
    Ojeda, E
    Jiménez, V
    Jiménez, MT
    Hernández, D
    Alvárez, MT
    Martín, MP
    Bustos, JG
    Aguado, MJ
    Navarro, FH
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S205 - S205
  • [3] LONG TERM SURVIVAL FOLLOWING HIGH DOSE SEQUENTIAL CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC CELL RESCUE FOR MULTIPLE MYELOMA
    Doan, P.
    Gasparetto, C.
    Chute, J.
    Horwitz, M.
    Rizzieri, D.
    Sullivan, K.
    Edwards, J.
    Jacobson, R.
    Corbet, K.
    Chao, N.
    Long, G.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S201 - S201
  • [4] High-dose chemotherapy and autotransplants for plasma cell myeloma in Jordan
    Khalid Halahleh
    Mohammad Ma’koseh
    Husam Abu-Jazar
    Sameer Yaser
    Hani Howar
    Mohamad AL-Rawashdeh
    Abdelghani Tbakhi
    Rula Najjar
    Nilly Hussein
    Dalia Al-Rimawi
    Robert Peter Gale
    Mahmoud Sarhan
    [J]. Bone Marrow Transplantation, 2018, 53 : 1349 - 1350
  • [5] High-dose chemotherapy and autotransplants for plasma cell myeloma in Jordan
    Halahleh, Khalid
    Ma'koseh, Mohammad
    Abu-Jazar, Husam
    Yaser, Sameer
    Howar, Hani
    AL-Rawashdeh, Mohamad
    Tbakhi, Abdelghani
    Najjar, Rula
    Hussein, Nilly
    Al-Rimawi, Dalia
    Gale, Robert Peter
    Sarhan, Mahmoud
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (10) : 1349 - 1350
  • [6] High dose sequential chemotherapy and autologous peripheral stem cell transplantation in patients with previously treated or untreated multiple myeloma
    Kuhlmann, S
    Fossa, A
    Wrzeciono, T
    Kasper, C
    Welt, A
    Seeber, S
    Nowrousian, MR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 352 - 353
  • [7] HIGH DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA
    Ali, N.
    Shaikh, M. U.
    Adil, S.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : 5627 - 5627
  • [8] High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S385 - S385
  • [9] Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma
    Ballestrero, A
    Ferrando, F
    Miglino, M
    Clavio, M
    Gonella, R
    Garuti, A
    Grasso, R
    Ghio, R
    Balleari, E
    Gobbi, M
    Patrone, F
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (02) : 101 - 106
  • [10] High-dose chemotherapy with sequential double cycles of cyclophosphamide and melphalan in patients with multiple myeloma.
    Nowrousian, MR
    Wrzeciono, T
    Tewes, M
    Fossa, A
    Welt, A
    Schuett, P
    Brandhorst, D
    Kloke, O
    Schuette, J
    Seeber, S
    [J]. BLOOD, 2000, 96 (11) : 421A - 421A